John Prybylski

John Prybylski is a Pharmacometrician at Biogen, where they currently serve as the Scientific Director of Pharmacometrics. They previously worked as a Pharmacometrician at Pfizer from 2020 to 2025, focusing on pharmacokinetics/pharmacodynamics (PK/PD) and regulatory modeling. John also completed a postdoctoral fellowship at the University of North Carolina at Chapel Hill, assessing HIV latency reversal agents. They obtained a Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and a Doctor of Pharmacy degree, summa cum laude, from the University of Florida. Prior to their advanced studies, John earned an Associate’s Degree in Pre-Pharmacy/Biochemistry from the University of West Florida.